-
1
-
-
0038236731
-
Magnetic resonance imaging at 3.0 Tesla: Challenges and advantages in clinical neurological imaging
-
DOI 10.1097/00004424-200307000-00003
-
Frayne R, Goodyear BG, Dickhoff P, Lauzon ML, Sevick RJ. Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 2003; 38:385-402 (Pubitemid 36791332)
-
(2003)
Investigative Radiology
, vol.38
, Issue.7
, pp. 385-402
-
-
Frayne, R.1
Goodyear, B.G.2
Dickhoff, P.3
Lauzon, M.L.4
Sevick, R.J.5
-
3
-
-
0034756917
-
Central nervous system: Review of clinical use of contrast media
-
DOI 10.1097/00002142-200108000-00003
-
Runge VM, Muroff LR, Jinkins JR. Central nervous system: review of clinical use of contrast media. Top Magn Reson Imaging 2001; 12:231-263 (Pubitemid 33031396)
-
(2001)
Topics in Magnetic Resonance Imaging
, vol.12
, Issue.4
, pp. 231-263
-
-
Runge, V.M.1
Muroff, L.R.2
Jinkins, J.R.3
-
4
-
-
34247540312
-
White matter damage in Alzheimer disease and mild cognitive impairment: Assessment with diffusion-tensor MR imaging and parallel imaging techniques
-
DOI 10.1148/radiol.2432051714
-
Stahl R, Dietrich O, Teipel SJ, Hampel H, Reise MF, Schoenberg SO. White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. Radiology 2007; 243:483-492 (Pubitemid 46649705)
-
(2007)
Radiology
, vol.243
, Issue.2
, pp. 483-492
-
-
Stahl, R.1
Dietrich, O.2
Teipel, S.J.3
Hampel, H.4
Reiser, M.F.5
Schoenberg, S.O.6
-
5
-
-
60549106702
-
Use of MRI to estimate the therapeutic window in acute stroke: Is perfusionweighted imaging/diffusion-weighted imaging mismatch an EPITHET for salvageable ischemic brain tissue?
-
Toth G, Albers GW. Use of MRI to estimate the therapeutic window in acute stroke: is perfusionweighted imaging/diffusion-weighted imaging mismatch an EPITHET for salvageable ischemic brain tissue? Stroke 2009; 40:333-335
-
(2009)
Stroke
, vol.40
, pp. 333-335
-
-
Toth, G.1
Albers, G.W.2
-
6
-
-
0035125779
-
Detection of intracranial metastases: A multicenter, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dosage
-
DOI 10.1097/00004424-200102000-00002
-
Colosimo C, Ruscalleda J, Korves M, et al. Detection of intracranial metastases: a multicenter, intrapatient comparison of gadobenate dimeglumineenhanced MRI with routinely used contrast agents at equal dosage. Invest Radiol 2001; 36: 72-81 (Pubitemid 32147853)
-
(2001)
Investigative Radiology
, vol.36
, Issue.2
, pp. 72-81
-
-
Colosimo, C.1
Ruscalleda, J.2
Korves, M.3
La Ferla, R.4
Wool, C.5
Pianezzola, P.6
Kirchin, M.A.7
-
7
-
-
33746224273
-
Contrast enhancement of central nervous system lesions: Multicenter intraindividual crossover comparative study of two MR contrast agents
-
Maravilla KR, Maldjian JA, Schmalfuss IM, et al. Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents. Radiology 2006; 240:389-400
-
(2006)
Radiology
, vol.240
, pp. 389-400
-
-
Maravilla, K.R.1
Maldjian, J.A.2
Schmalfuss, I.M.3
-
8
-
-
33745904734
-
Update on brain tumor imaging: From anatomy to physiology
-
Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR 2006; 27:475-487 (Pubitemid 44897763)
-
(2006)
American Journal of Neuroradiology
, vol.27
, Issue.3
, pp. 475-487
-
-
Cha, S.1
-
9
-
-
33847241851
-
Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 H gadolinium chelates for detecting multiple sclerosis lesions
-
DOI 10.2214/AJR.05.2212
-
Uysal E, Erturk SM, Yildirim H, Seleker F, Basak M. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions. AJR 2007; 188:697-702 (Pubitemid 46303193)
-
(2007)
American Journal of Roentgenology
, vol.188
, Issue.3
, pp. 697-702
-
-
Uysal, E.1
Erturk, S.M.2
Yildirim, H.3
Seleker, F.4
Basak, M.5
-
10
-
-
27744558426
-
Brain tumors: Full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T - Initial experience
-
DOI 10.1148/radiol.2373041672
-
Krautmacher C, Willinek WA, Tschampa HJ, et al. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T, initial experience. Radiology 2005; 237:1014-1019 (Pubitemid 41636395)
-
(2005)
Radiology
, vol.237
, Issue.3
, pp. 1014-1019
-
-
Krautmacher, C.1
Willinek, W.A.2
Tschampa, H.J.3
Born, M.4
Traber, F.5
Gieseke, J.6
Textor, H.J.7
Schild, H.H.8
Kuhl, C.K.9
-
11
-
-
33646381138
-
Magnetic resonance imaging at 3.0 tesla detects more lesions in acute optic neuritis than at 1.5 tesla
-
DOI 10.1097/01.rli.0000188364.76251.28, PII 0000442420060200000003
-
Nielsen K, Rostrup E, Frederiksen JL, et al. Magnetic resonance imaging at 3.0 tesla detects more lesions in acute optic neuritis than at 1.5 tesla. Invest Radiol 2006; 41:76-82 (Pubitemid 44406202)
-
(2006)
Investigative Radiology
, vol.41
, Issue.2
, pp. 76-82
-
-
Nielsen, K.1
Rostrup, E.2
Frederiksen, J.L.3
Knudsen, S.4
Mathiesen, H.K.5
Hanson, L.G.6
Paulson, O.B.7
-
12
-
-
0036119659
-
Magnetic resonance imaging contrast enhancement of brain tumors at 3 tesla versus 1.5 tesla
-
DOI 10.1097/00004424-200203000-00003
-
Nobauer-Huhmann IM, Ba-Ssalamah A, Mlynarik V, et al. Magnetic resonance imaging contrast enhancement of brain tumors at 3 tesla versus 1.5 tesla. Invest Radiol 2002; 37:114-119 (Pubitemid 34225507)
-
(2002)
Investigative Radiology
, vol.37
, Issue.3
, pp. 114-119
-
-
Nobauer-Huhmann, I.-M.1
Ba-Ssalamah, A.2
Mlynarik, V.3
Barth, M.4
Schoggl, A.5
Heimberger, K.6
Matula, C.7
Fog, A.8
Kaider, A.9
Trattnig, S.10
-
13
-
-
28044451074
-
Brain tumor enhancement in magnetic resonance imaging: Comparison of signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) at 1.5 versus 3 tesla
-
DOI 10.1097/01.rli.0000187609.78338.dc
-
Biswas J, Nelson CB, Runge VM, et al. Brain tumor enhancement in magnetic resonance imaging: comparison of signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) at 1.5 versus 3 tesla. Invest Radiol 2005; 40:792-797 (Pubitemid 41690437)
-
(2005)
Investigative Radiology
, vol.40
, Issue.12
, pp. 792-797
-
-
Biswas, J.1
Nelson, C.B.2
Runge, V.M.3
Wintersperger, B.J.4
Baumann, S.S.5
Jackson, C.B.6
Patel, T.7
-
14
-
-
33745893815
-
The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: Comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model
-
DOI 10.1097/01.rli.0000191332.24773.e7, PII 0000442420060300000006
-
Runge VM, Biswas J, Wintersperger BJ, et al. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model. Invest Radiol 2006; 41:244-248 (Pubitemid 44406184)
-
(2006)
Investigative Radiology
, vol.41
, Issue.3
, pp. 244-248
-
-
Runge, V.M.1
Biswas, J.2
Wintersperger, B.J.3
Baumann, S.S.4
Jackson, C.B.5
Herborn, C.U.6
Patel, T.7
-
15
-
-
0028235163
-
Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases
-
Yuh WT, Fisher DJ, Runge VM, et al. Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases. AJNR 1994; 15:1037-1051
-
(1994)
AJNR
, vol.15
, pp. 1037-1051
-
-
Yuh, W.T.1
Fisher, D.J.2
Runge, V.M.3
-
16
-
-
66949131763
-
Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla
-
Giesel FL, Mehndiratta A, Risse F, et al. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla. Acta Radiol 2009; 50:521-530
-
(2009)
Acta Radiol
, vol.50
, pp. 521-530
-
-
Giesel, F.L.1
Mehndiratta, A.2
Risse, F.3
-
17
-
-
67651047054
-
Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T
-
Attenberger UI, Runge VM, Jackson CB, et al. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T. Invest Radiol 2009; 44:251-256
-
(2009)
Invest Radiol
, vol.44
, pp. 251-256
-
-
Attenberger, U.I.1
Runge, V.M.2
Jackson, C.B.3
-
18
-
-
27544442176
-
Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths
-
DOI 10.1097/01.rli.0000184756.66360.d3
-
Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40:715-724 (Pubitemid 41546838)
-
(2005)
Investigative Radiology
, vol.40
, Issue.11
, pp. 715-724
-
-
Rohrer, M.1
Bauer, H.2
Mintorovitch, J.3
Requardt, M.4
Weinmann, H.-J.5
-
19
-
-
59649103411
-
Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C
-
Frenzel T, Lengsfeld P, Schirmer H, Hütter J, Weinmann HJ. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest Radiol 2008; 43:817-828
-
(2008)
Invest Radiol
, vol.43
, pp. 817-828
-
-
Frenzel, T.1
Lengsfeld, P.2
Schirmer, H.3
Hütter, J.4
Weinmann, H.J.5
-
20
-
-
52049085751
-
Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions
-
Sieber MA, Lengsfeld P, Frenzel T, et al. Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions. Eur Radiol 2008; 18:2164-2173
-
(2008)
Eur Radiol
, vol.18
, pp. 2164-2173
-
-
Sieber, M.A.1
Lengsfeld, P.2
Frenzel, T.3
-
21
-
-
42949099288
-
Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: The role of excess ligand
-
DOI 10.1002/jmri.21368
-
Sieber MA, Lengsfeld P, Walter J, et al. Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: the role of excess ligand. J Magn Reson Imaging 2008; 27:955-962 (Pubitemid 351614604)
-
(2008)
Journal of Magnetic Resonance Imaging
, vol.27
, Issue.5
, pp. 955-962
-
-
Sieber, M.A.1
Lengsfeld, P.2
Walter, J.3
Schirmer, H.4
Frenzel, T.5
Siegmund, F.6
Weinmann, H.-J.7
Pietsch, H.8
-
22
-
-
37549017297
-
A preclinical study to investigate the development of nephrogenic systemic fibrosis: A possible role for gadolinium-based contrast media
-
Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media. Invest Radiol 2008; 43:65-75
-
(2008)
Invest Radiol
, vol.43
, pp. 65-75
-
-
Sieber, M.A.1
Pietsch, H.2
Walter, J.3
Haider, W.4
Frenzel, T.5
Weinmann, H.J.6
-
23
-
-
63849097300
-
Gadolinium and nephrogenic systemic fibrosis
-
web
-
Runge VM. Gadolinium and nephrogenic systemic fibrosis. AJR 2009; 192: [web]W195-W196
-
(2009)
AJR
, vol.192
-
-
Runge, V.M.1
-
24
-
-
42449084017
-
Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue
-
DOI 10.2214/AJR.07.2822
-
Wiginton CD, Kelly B, Oto A, et al. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. AJR 2008; 190:1060-1068 (Pubitemid 351571526)
-
(2008)
American Journal of Roentgenology
, vol.190
, Issue.4
, pp. 1060-1068
-
-
Wiginton, C.D.1
Kelly, B.2
Oto, A.3
Jesse, M.4
Aristimuno, P.5
Ernst, R.6
Chaljub, G.7
-
25
-
-
57149102552
-
Assessment of adverse reaction rates to a newly approved MRI contrast agent: Review of 23,553 administrations of gadobenate dimeglumine
-
[web] W307-W311
-
Bleicher AG, Kanal E. Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine. AJR 2008; 191:1870; [web] W307-W311
-
(2008)
AJR
, vol.191
, pp. 1870
-
-
Bleicher, A.G.1
Kanal, E.2
-
26
-
-
0036135655
-
Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: Safety and dialysability
-
Tombach B, Bremer C, Reimer P, et al. Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: safety and dialysability. AJR 2002; 178:105-109 (Pubitemid 34016382)
-
(2002)
American Journal of Roentgenology
, vol.178
, Issue.1
, pp. 105-109
-
-
Tombach, B.1
Bremer, C.2
Reimer, P.3
Matzkies, F.4
Schaefer, R.M.5
Ebert, W.6
Geens, V.7
Eisele, J.8
Heindel, W.9
-
27
-
-
34547879249
-
Measurement of signal-to-noise ratios in MR images: Influence of multichannel coils, parallel imaging, and reconstruction filters
-
DOI 10.1002/jmri.20969
-
Dietrich O, Raya JG, Reeder SB, Reiser MF, Schoenberg SO. Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging 2007; 26:375-385 (Pubitemid 47257737)
-
(2007)
Journal of Magnetic Resonance Imaging
, vol.26
, Issue.2
, pp. 375-385
-
-
Dietrich, O.1
Raya, J.G.2
Reeder, S.B.3
Reiser, M.F.4
Schoenberg, S.O.5
-
28
-
-
33645743790
-
Genetic characterization of commonly used glioma cell lines in the rat animal model system
-
Sibenaller ZA, Etame AB, Ali MM, et al. Genetic characterization of commonly used glioma cell lines in the rat animal model system. Neurosurg Focus 2005; 19:E1
-
(2005)
Neurosurg Focus
, vol.19
-
-
Sibenaller, Z.A.1
Etame, A.B.2
Ali, M.M.3
|